Literature DB >> 16251324

Kinetics study of KPC-3, a plasmid-encoded class A carbapenem-hydrolyzing beta-lactamase.

Jimena Alba1, Yoshikazu Ishii, Kenneth Thomson, Ellen Smith Moland, Keizo Yamaguchi.   

Abstract

The kinetic activity of KPC-3, a plasmid-encoded class A carbapenemase, was studied. It hydrolyzed penicillins, cephalosporins, carbapenems, and even sulbactam. The best substrate was cephalothin (k(cat/K)m = 3.48 microM(-1) s(-1)). The efficiency of the enzyme was similar for imipenem and meropenem (k(cat)/K(m), 1.4 and 1.94 microM(-1) s(-1), respectively).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16251324      PMCID: PMC1280115          DOI: 10.1128/AAC.49.11.4760-4762.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  30 in total

Review 1.  Important and emerging beta-lactamase-mediated resistances in hospital-based pathogens: the Amp C enzymes.

Authors:  R N Jones
Journal:  Diagn Microbiol Infect Dis       Date:  1998-07       Impact factor: 2.803

2.  Biochemical characterization of a beta-lactamase that hydrolyzes penems and carbapenems from two Serratia marcescens isolates.

Authors:  Y J Yang; P J Wu; D M Livermore
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

3.  Characterization of IMI-1 beta-lactamase, a class A carbapenem-hydrolyzing enzyme from Enterobacter cloacae.

Authors:  B A Rasmussen; K Bush; D Keeney; Y Yang; R Hare; C O'Gara; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

Review 4.  A functional classification scheme for beta-lactamases and its correlation with molecular structure.

Authors:  K Bush; G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

5.  Mechanisms responsible for reduced susceptibility to imipenem in Bacteroides fragilis.

Authors:  R Edwards; D Greenwood
Journal:  J Antimicrob Chemother       Date:  1996-12       Impact factor: 5.790

6.  Novel GES/IBC extended-spectrum beta-lactamase variants with carbapenemase activity in clinical enterobacteria.

Authors:  Sofia Vourli; Panagiota Giakkoupi; Vivi Miriagou; Eva Tzelepi; Alkiviadis C Vatopoulos; Leonidas S Tzouvelekis
Journal:  FEMS Microbiol Lett       Date:  2004-05-15       Impact factor: 2.742

7.  Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City.

Authors:  Patricia A Bradford; Simona Bratu; Carl Urban; Melissa Visalli; Noriel Mariano; David Landman; James J Rahal; Steven Brooks; Sanda Cebular; John Quale
Journal:  Clin Infect Dis       Date:  2004-06-14       Impact factor: 9.079

8.  Carbapenem-resistant strain of Klebsiella oxytoca harboring carbapenem-hydrolyzing beta-lactamase KPC-2.

Authors:  Hesna Yigit; Anne Marie Queenan; J Kamile Rasheed; James W Biddle; Antonio Domenech-Sanchez; Sebastian Alberti; Karen Bush; Fred C Tenover
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

9.  Molecular characterization of a carbapenem-hydrolyzing class A beta-lactamase, SFC-1, from Serratia fonticola UTAD54.

Authors:  Isabel Henriques; Alexandra Moura; Artur Alves; Maria José Saavedra; António Correia
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

10.  Biochemical properties of a carbapenem-hydrolyzing beta-lactamase from Enterobacter cloacae and cloning of the gene into Escherichia coli.

Authors:  P Nordmann; S Mariotte; T Naas; R Labia; M H Nicolas
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

View more
  30 in total

1.  Characteristics of meropenem heteroresistance in Klebsiella pneumoniae carbapenemase (KPC)-producing clinical isolates of K. pneumoniae.

Authors:  Spyros Pournaras; Ioulia Kristo; Georgia Vrioni; Alexandros Ikonomidis; Aggeliki Poulou; Dimitra Petropoulou; Athanassios Tsakris
Journal:  J Clin Microbiol       Date:  2010-05-26       Impact factor: 5.948

Review 2.  Carbapenemases: the versatile beta-lactamases.

Authors:  Anne Marie Queenan; Karen Bush
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

3.  bla(KPC) RNA expression correlates with two transcriptional start sites but not always with gene copy number in four genera of Gram-negative pathogens.

Authors:  Amanda L Roth; Philip M Kurpiel; Philip D Lister; Nancy D Hanson
Journal:  Antimicrob Agents Chemother       Date:  2011-05-16       Impact factor: 5.191

4.  Microbiological and Genetic Characterization of Carbapenem-Resistant Klebsiella pneumoniae Isolated From Pediatric Patients.

Authors:  Jasmeen S Dara; Liang Chen; Michael H Levi; Barry N Kreiswirth; Rebecca Pellett Madan
Journal:  J Pediatric Infect Dis Soc       Date:  2013-08-20       Impact factor: 3.164

5.  Exploring the role of a conserved class A residue in the Ω-Loop of KPC-2 β-lactamase: a mechanism for ceftazidime hydrolysis.

Authors:  Peter S Levitt; Krisztina M Papp-Wallace; Magdalena A Taracila; Andrea M Hujer; Marisa L Winkler; Kerri M Smith; Yan Xu; Michael E Harris; Robert A Bonomo
Journal:  J Biol Chem       Date:  2012-07-26       Impact factor: 5.157

Review 6.  Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions.

Authors:  L S Tzouvelekis; A Markogiannakis; M Psichogiou; P T Tassios; G L Daikos
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

7.  Direct detection and genotyping of Klebsiella pneumoniae carbapenemases from urine by use of a new DNA microarray test.

Authors:  Harald Peter; Kathrine Berggrav; Peter Thomas; Yvonne Pfeifer; Wolfgang Witte; Kate Templeton; Till T Bachmann
Journal:  J Clin Microbiol       Date:  2012-10-03       Impact factor: 5.948

8.  Antibiotic resistance and substrate profiles of the class A carbapenemase KPC-6.

Authors:  Toni L Lamoureaux; Hilary Frase; Nuno T Antunes; Sergei B Vakulenko
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

9.  A novel extended-spectrum β-lactamase, SGM-1, from an environmental isolate of Sphingobium sp.

Authors:  Toni L Lamoureaux; Viktoria Vakulenko; Marta Toth; Hilary Frase; Sergei B Vakulenko
Journal:  Antimicrob Agents Chemother       Date:  2013-05-28       Impact factor: 5.191

10.  KPC-9, a novel carbapenemase from clinical specimens in Israel.

Authors:  Carlos Hidalgo-Grass; Gabriela Warburg; Violeta Temper; Shmuel Benenson; Allon E Moses; Colin Block; Jacob Strahilevitz
Journal:  Antimicrob Agents Chemother       Date:  2012-09-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.